Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Modular Medical, Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at cash fee equal to 7% of the gross proceeds (effective 2026-03-03).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Maxim Group LLC
- Value
- cash fee equal to 7% of the gross proceeds
- Effective
- 2026-03-03
Exact text from the filing
On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses. Pursuant to the Placement Agency Agreement, the Company paid the Placement Agent a cash fee equal to 7% of the gross proceeds received from the Offering and reimbursed the Placement Agent for its expe
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Modular Medical, Inc. entered into Securities Purchase Agreements with multiple investors valued at gross proceeds of approximately $12 million (effective 2026-03-03).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- multiple investors
- Value
- gross proceeds of approximately $12 million
- Effective
- 2026-03-03
Exact text from the filing
On March 3, 2026, Modular Medical, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”) and securities purchase agreements (the “Securities Purchase Agreements”) with multiple investors, relating to a best-efforts offering (the “Offering”) of (i) 62,098,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) pre-funded warrants (the “pre-funded warrants”) to purchase 6,000,000 shares of Common Stock, and (iii) accompanying warrants exercisable to purchase up to 68,098,000 shares of Common Stock (the “common warrants”). The Company received gross proceeds of approximately $12 million from the Offering, before deducting placement agent fees and offering expenses.
View on SEC.gov